Quarterly report pursuant to Section 13 or 15(d)

EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST (Tables)

v3.21.1
EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST (Tables)
 9 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Combined Activity Under Equity Incentive Plans
The following table summarizes the combined activity under our equity incentive plans:
(In thousands)
Available
 For Grant(1) (2)
Balance as of June 30, 2020 10,760 
Restricted stock units granted(3)
(623)
Restricted stock units granted adjustment(4)
102 
Restricted stock units canceled 116 
Balance as of March 31, 2021 10,355 
__________________ 
(1)The number of RSUs reflects the application of the award multiplier of 2.0x to calculate the impact of the award on the shares reserved under the 2004 Plan.
(2)No additional stock options, RSUs or other awards will be granted under the Assumed Equity Plans.
(3)Includes RSUs granted to senior management during the nine months ended March 31, 2021 with performance-based vesting criteria (in addition to service-based vesting criteria for any of such RSUs that are deemed to have been earned) (“performance-based RSUs”). This line item includes all such performance-based RSUs granted during the nine months ended March 31, 2021 reported at the maximum possible number of shares that may ultimately be issuable if all applicable performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied (0.2 million shares for the nine months ended March 31, 2021 reflects the application of the multiplier described above).
(4)Represents the portion of RSUs granted with performance-based vesting criteria and reported at the actual number of shares issued upon achievement of the performance vesting criteria during the nine months ended March 31, 2021.
Schedule of Stock-based Compensation Expense
The following table shows stock-based compensation expense for the indicated periods: 
Three Months Ended Nine Months Ended
March 31, March 31,
(In thousands) 2021 2020 2021 2020
Stock-based compensation expense by:
Costs of revenues $ 4,779  $ 4,162  $ 12,550  $ 10,389 
Research and development 6,518  6,577  17,214  16,936 
Selling, general and administrative 19,030  20,531  54,382  57,678 
Total stock-based compensation expense $ 30,327  $ 31,270  $ 84,146  $ 85,003 
Schedule of Restricted Stock Activity
The following table shows the activity and weighted-average grant date fair values for RSUs during the nine months ended March 31, 2021:
Shares(1)
(In thousands)
 Weighted-Average
Grant Date
Fair Value
Outstanding restricted stock units as of June 30, 2020(2)
2,253  $ 107.33 
Granted(3)
311  $ 203.19 
Granted adjustments (51) $ 80.27 
Vested and released (445) $ 101.67 
Withheld for taxes (194) $ 101.67 
Forfeited (69) $ 119.34 
Outstanding restricted stock units as of March 31, 2021(2)
1,805  $ 125.58 
__________________ 
(1)Share numbers reflect actual shares subject to awarded RSUs.
(2)Includes performance-based and market-based RSUs.
(3)This line item includes performance-based RSUs granted during the nine months ended March 31, 2021 reported at the maximum possible number of shares that may ultimately be issuable if all applicable performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied (0.1 million shares for the nine months ended March 31, 2021).
Schedule of Grant Date Fair Value, Weighted Average Grant Date Fair Value, and Tax Benefits for Restricted Stock Units
The following table shows the weighted-average grant date fair value per unit for the RSUs granted, vested, and tax benefits realized by us in connection with vested and released RSUs for the indicated periods:
Three Months Ended Nine Months Ended
March 31, March 31,
(In thousands, except for weighted-average grant date fair value) 2021 2020 2021 2020
Weighted-average grant date fair value per unit $ 302.26  $ 168.92  $ 203.19  $ 142.93 
Grant date fair value of vested restricted stock units $ 14,436  $ 22,459  $ 65,005  $ 79,194 
Tax benefits realized by us in connection with vested and released restricted stock units $ 4,332  $ 4,942  $ 17,763  $ 18,596 
Schedule of Employee Stock Purchase Rights Valuation
The fair value of each purchase right under the ESPP was estimated on the date of grant using the Black-Scholes model and the straight-line attribution approach with the following weighted-average assumptions: 
Three Months Ended Nine Months Ended
  March 31, March 31,
  2021 2020 2021 2020
Stock purchase plan:
Expected stock price volatility 42.1  % 37.0  % 47.0  % 34.3  %
Risk-free interest rate 0.1  % 1.8  % 0.4  % 2.1  %
Dividend yield 1.4  % 1.9  % 1.6  % 2.2  %
Expected life (in years) 0.5 0.5 0.5 0.5
Schedule of Tax Benefits Realized and Weighted-average fair value for the ESPP
The following table shows total cash received from employees for the issuance of shares under the ESPP, the number of shares purchased by employees through the ESPP, the tax benefits realized by us in connection with the disqualifying dispositions of shares purchased under the ESPP and the weighted-average fair value per share for the indicated periods:
Three Months Ended Nine Months Ended
(In thousands, except for weighted-average fair value per share) March 31, March 31,
2021 2020 2021 2020
Total cash received from employees for the issuance of shares under the ESPP $ —  $ —  $ 26,356  $ 24,500 
Number of shares purchased by employees through the ESPP —  —  161  237 
Tax benefits realized by us in connection with the disqualifying dispositions of shares purchased under the ESPP $ 722  $ 945  $ 1,886  $ 2,798 
Weighted-average fair value per share based on Black-Scholes model $ 64.42  $ 43.36  $ 59.86  $ 36.70